A Novel Genetically Modified Mouse Seizure Model for Evaluating Anticonvulsive and Neuroprotective Efficacy of an A1 Adenosine Receptor Agonist following Soman Intoxication
Abstract
Recently a novel humanized mouse strain has been successfully generated, in which serum carboxylesterase (CES) knock out (KO) mice (Es1-/-) were further genetically modified by knocking in (KI), or adding, the gene that encodes the human form of acetylcholinesterase (AChE). The resulting human AChE KI and serum CES KO (or KIKO) mouse strain should not only exhibit organophosphorus nerve agent (NA) intoxication in a manner more similar to humans, but also display AChE-specific treatment responses more closely mimicking those of humans to facilitate data translation to pre-clinic trials. In this study, we utilized the KIKO mouse to develop a seizure model for NA medical countermeasure investigation, and then applied it to evaluate the anticonvulsant and neuroprotectant (A/N) efficacy of an A1 adenosine receptor (A1AR) agonist, N-bicyclo-(2.2.1)hept-2-yl-5'-chloro-5'-deoxyadenosine (ENBA), which has been shown in a rat seizure model to be a potent A/N compound.The findings confirmed that ENBA is a potent A/N for both immediate and delayed therapy to victims of NA exposure and serves as a promising treatment candidate for pre-clinical research and development for human application.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 27, 2022
- Accession Number
- AD1173902
Entities
People
- Tsung-Ming Shih